Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer
Clinical trial NCT01309126 · TERMINATED
Trial details
- NCT number
- NCT01309126
- Sponsor
- HiberCell, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2017-02-01
- Enrollment
- 217
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.